MARKET

CNTN

CNTN

Canton Strategic Holdings
NASDAQ
3.250
-0.010
-0.31%
Pre Market: 3.330 +0.08 +2.46% 04:01 04/07 EDT
OPEN
3.240
PREV CLOSE
3.260
HIGH
3.410
LOW
3.220
VOLUME
1
TURNOVER
0
52 WEEK HIGH
9.08
52 WEEK LOW
0.9520
MARKET CAP
184.13M
P/E (TTM)
-2.9000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CNTN last week (0330-0403)?
Weekly Report · 23h ago
Canton Strategic FY25 loss widens to $42 million; unrealized digital asset loss hits $22 million
Reuters · 6d ago
Canton Strategic net loss widens to $35.9 million in FY25; revenue remains no revenue
Reuters · 6d ago
Canton Strategic Highlights 2025 Results, Advances Digital Asset Focus
TipRanks · 6d ago
Canton Strategic GAAP EPS of -$1.12
Seeking Alpha · 6d ago
CANTON STRATEGIC HOLDINGS:TO IMPLEMENT STREAMLINED COST STRUCTURE FOLLOWING REALIZATION OF NON-RECURRING COMPENSATION, ADMINISTRATIVE COSTS IN Q1 2026
Reuters · 6d ago
CANTON STRATEGIC HOLDINGS REPORTS FULL YEAR 2025 FINANCIAL AND OPERATIONAL RESULTS
Reuters · 6d ago
Press Release: Canton Strategic Holdings Reports Full Year 2025 Financial and Operational Results
Dow Jones · 6d ago
More
About CNTN
Canton Strategic Holdings, Inc., formerly Tharimmune, Inc., is advancing institutional blockchain adoption to drive the digitization of financial markets. In addition to driving value through activities on the Canton Network, the Company operates a Super Validator, ensuring safe and secure transactions across the Network. The Company also operates a clinical-stage biotech research and development arm. Its lead clinical asset, GV104, is being developed for a specific indication via a 505(b)2 pathway for respiratory and/or nervous system depression in military personnel and chemical incident responders who may encounter high-potency opioids. The expanded pipeline includes other indications for GV104 and GV023, a new approach to autoimmune diseases, as well as an early-stage multispecific biologic platform.

Webull offers Canton Strategic Holdings Inc stock information, including NASDAQ: CNTN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNTN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CNTN stock methods without spending real money on the virtual paper trading platform.